Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

Antibody titer detection method

Antibody titer detection method, Total:173 items.

The international standard classification for "Antibody titer detection method" includes: Sterilization and disinfection , Cosmetics. Toiletries , Veterinary medicine , Other standards related to sterilization and disinfection , Inks. Printing inks , Other standards related to analytical chemistry , Chemicals for industrial and domestic disinfection purposes , Semi-manufactures of timber , Chemical analysis , Hospital equipment .

The Chinese standard classification for "Antibody titer detection method" includes: Sanitation in general , Cosmetics , Animal quarantine, veterinary and epidemic prevention , Basic standards and general methods for chemical additive , Other daily-use chemicals , Daily use chemicals in general , Tooth paste, soap and detergent , Timber and processed timber , Medical laboratory equipment , Medical sanitary products .


Professional Standard - Agriculture

  • 269药典 三部-2010 Appendix Ⅺ ⅪI Antivenom Serum Potency Determination
  • 315药典 三部-2020 Biological Activity-Potency Determination Method 3504 Adsorption Tetanus Vaccine Potency Determination Method
  • 274药典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • JAP-078 Trinexapac-ethyl detection method
  • 284药典 四部-2015 3500 Biological activity-potency assay 3521 Human blood coagulation factor Ⅷ potency assay
  • 284药典 三部-2015 Biological Activity-Potency Determination Method 3502 Hepatitis A Inactivated Vaccine Relative Potency Test Method in Vitro General Rules 120
  • 269药典 四部-2020 3500 Biological Activity - Potency Determination 3511 Antivenom Potency Determination
  • 283药典 四部-2015 3500 biological activity-potency assay 3520 human coagulation factor X potency assay
  • 279药典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • 343药典 三部-2020 Biological Activity - Potency Assay 3533 Botulinum Toxin Type A Potency Assay
  • 331药典 三部-2020 Biological Activity-Potency Assay 3520 Human Coagulation Factor X Potency Assay
  • 294药典 四部-2015 3500 Biological Activity-Potency Assay 3531 Nimotuzumab Biological Activity Assay
  • 278药典 四部-2020 3500 biological activity-potency assay 3520 human coagulation factor X potency assay
  • 282药典 四部-2015 3500 Biological Activity-Potency Assay 3519 Human Coagulation Factor IX Potency Assay
  • 290药典 三部-2015 Biological Activity - Potency Assay 3508 Tetanus Antitoxin Potency Assay General Rules 123
  • 291药典 三部-2015 Biological Activity - Potency Assay 3509 Gas Gangrene Antitoxin Potency Assay General Rules 123
  • 272药典 四部-2015 3500 Biological Activity - Potency Determination 3509 Gas Gangrene Antitoxin Potency Determination
  • 265药典 三部-2010 Appendix Ⅺ ⅪE Diphtheria Antitoxin Potency Assay
  • 324药典 三部-2020 Biological activity-potency determination method 3513 Diphtheria antibody titer determination method in human immunoglobulin
  • 263药典 四部-2020 3500 Biological Activity - Potency Determination 3505 Adsorption Diphtheria Vaccine Potency Determination
  • 329药典 三部-2020 Biological Activity-Potency Assay 3518 Human Coagulation Factor VII Potency Assay
  • 341药典 三部-2020 Biological Activity-Potency Assay 3531 Nimotuzumab Biological Activity Assay
  • 267药典 三部-2010 Appendix Ⅺ ⅪG Gas Gangrene Antitoxin Potency Determination
  • 295药典 三部-2015 Biological activity-potency assay 3513 General rules for diphtheria antibody titer assay in human immunoglobulin 127
  • 273药典 四部-2020 3500 Biological Activity - Potency Assay 3515 Anti-Human T Cell Immunoglobulin Potency Assay (E Rosette Formation Inhibition Test)
  • 318药典 三部-2020 Biological Activity - Potency Assay 3507 Diphtheria Antitoxin Potency Assay
  • 322药典 三部-2020 Biological Activity - Potency Assay 3511 Antivenom Potency Assay
  • 278药典 四部-2015 3500 Biological Activity - Potency Assay 3515 Anti-Human T Cell Immunoglobulin Potency Assay (E Rosette Formation Inhibition Test)
  • 292药典 三部-2015 Biological Activity - Potency Assay 3510 General Rules of Botulinum Antitoxin Potency Assay 124
  • 312药典 三部-2020 Biological Activity-Potency Determination Method 3501 Recombinant Hepatitis B Vaccine (Yeast) In Vitro Relative Potency Test Method
  • 293药典 三部-2015 Biological Activity - Potency Assay 3511 Antivenom Potency Assay General Rules 125
  • 275药典 四部-2020 3500 Biological activity-potency assay 3517 Human coagulation factor Ⅱ potency assay
  • 271药典 四部-2020 3500 Biological activity-potency assay 3513 Diphtheria antibody titer assay in human immunoglobulin
  • 268药典 三部-2010 Appendix Ⅺ ⅪH Botulinum Antitoxin Potency Determination Method
  • 297药典 三部-2015 Biological activity-potency assay 3515 Anti-human T cell immunoglobulin titer assay (E rosette formation inhibition test) General 129
  • NY/T 2840-2015 Indirect ELISA for detection of antibodies against Porcme parvovirus
  • JAP-077 The detection method of tributaline
  • 268药典 四部-2020 3500 Biological Activity-Potency Assay 3510 Botulinum Antitoxin Potency Assay
  • 273药典 四部-2015 3500 Biological Activity-Potency Assay 3510 Botulinum Antitoxin Potency Assay
  • 264药典 四部-2015 3500 Biological Activity-Potency Determination Method 3501 Recombinant Hepatitis B Vaccine (Yeast) In Vitro Relative Potency Test Method
  • 268药典 四部-2015 3500 Biological Activity - Potency Determination 3505 Adsorption Diphtheria Vaccine Potency Determination
  • 321药典 三部-2020 Biological Activity - Potency Assay 3510 Botulinum Antitoxin Potency Assay
  • 276药典 四部-2020 3500 Biological Activity-Potency Assay 3518 Human Coagulation Factor VII Potency Assay
  • 276药典 四部-2015 3500 Biological activity-potency assay 3513 Diphtheria antibody titer assay in human immunoglobulin
  • 281药典 四部-2015 3500 Biological Activity-Potency Assay 3518 Human Coagulation Factor VII Potency Assay
  • 326药典 三部-2020 Biological Activity - Potency Assay 3515 Anti-Human T Cell Immunoglobulin Potency Assay (E Rosette Formation Inhibition Test)
  • 265药典 四部-2015 3500 Biological Activity-Potency Determination Method 3502 Hepatitis A Inactivated Vaccine Relative Potency Test Method in Vitro
  • 327药典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
  • 330药典 三部-2020 Biological Activity-Potency Assay 3519 Human Coagulation Factor IX Potency Assay
  • 289药典 三部-2015 Biological Activity - Potency Assay 3507 Diphtheria Antitoxin Potency Assay General Rules 122
  • 332药典 三部-2020 Biological Activity-Potency Assay 3521 Human Coagulation Factor Ⅷ Potency Assay
  • 313药典 三部-2020 Biological Activity-Potency Determination Method 3502 Hepatitis A Inactivated Vaccine Relative Potency Test Method in Vitro
  • 266药典 四部-2020 3500 Biological Activity-Potency Assay 3508 Tetanus Antitoxin Potency Assay
  • 283药典 三部-2015 Biological Activity - Potency Determination Method 3501 Recombinant Hepatitis B Vaccine (Yeast) In Vitro Relative Potency Test Method 119
  • 260药典 四部-2020 3500 Biological Activity-Potency Determination Method 3502 Hepatitis A Inactivated Vaccine Relative Potency Test Method in Vitro
  • 256药典 三部-2010 Appendix Ⅹ XO Diphtheria Antibody Titer Determination Method in Human Immunoglobulin
  • 267药典 四部-2020 3500 Biological Activity - Potency Determination 3509 Gas Gangrene Antitoxin Potency Determination
  • 277药典 四部-2020 3500 Biological Activity-Potency Assay 3519 Human Coagulation Factor IX Potency Assay
  • 320药典 三部-2020 Biological Activity - Potency Assay 3509 Gas Gangrene Antitoxin Potency Assay
  • 298药典 三部-2015 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test) General 129
  • 259药典 四部-2020 3500 Biological Activity-Potency Determination Method 3501 Recombinant Hepatitis B Vaccine (Yeast) In Vitro Relative Potency Test Method
  • 280药典 四部-2015 3500 Biological activity-potency assay 3517 Human coagulation factor Ⅱ potency assay
  • 291药典 四部-2020 3500 Biological Activity-Potency Assay 3533 Type A Botulinum Toxin Potency Assay
  • 266药典 三部-2010 Appendix Ⅺ ⅪF Tetanus Antitoxin Potency Assay
  • 270药典 四部-2015 3500 Biological Activity-Potency Assay 3507 Diphtheria Antitoxin Potency Assay
  • 265药典 四部-2020 3500 Biological Activity-Potency Assay 3507 Diphtheria Antitoxin Potency Assay
  • 319药典 三部-2020 Biological Activity - Potency Assay 3508 Tetanus Antitoxin Potency Assay
  • 279药典 四部-2020 3500 Biological activity-potency assay 3521 Human blood coagulation factor Ⅷ potency assay
  • 314药典 三部-2020 Biological Activity-Potency Determination Method 3503 Human Rabies Vaccine Potency Determination Method
  • 274药典 四部-2015 3500 Biological Activity - Potency Determination 3511 Antivenom Potency Determination
  • 328药典 三部-2020 Biological Activity-Potency Assay 3517 Human Coagulation Factor Ⅱ Potency Assay
  • 271药典 四部-2015 3500 Biological Activity-Potency Assay 3508 Tetanus Antitoxin Potency Assay
  • 316药典 三部-2020 Biological Activity-Potency Determination Method 3505 Adsorption Diphtheria Vaccine Potency Determination Method
  • 296药典 四部-2015 3500 Biological Activity-Potency Assay 3533 Type A Botulinum Toxin Potency Assay
  • 289药典 四部-2020 3500 Biological Activity-Potency Assay 3531 Nimotuzumab Biological Activity Assay

Guangdong Provincial Standard of the People's Republic of China

  • DB44/T 1211-2013 Energy Efficiency Detection and Evaluation Method of Water Pump Unit
  • DB44/T 1209-2013 Energy Efficiency Detection and Evaluation Method for Fan Units

卫生健康委员会

  • WS/T 685-2020 Analytical method and evaluation requirements of antifungal drugs in disinfectant and antibactertial and bacteriostatic agents
  • WS/T 684-2020 Analytical method and evaluation requirements for antibacterial drugs in disinfectant and antibacterial and bacteriostatic agents
  • WS/T 650-2019 Evaluting Method for Efficacy of Antibacterial and Bacteriostasis
  • WS/T 686-2020 Analytical method and evaluation requirements of antiviral drugs in disinfectant and antibacterial and bacteriostatic agents

Group Standards of the People's Republic of China

  • T/LNBHXH 005-2023 Test method for in vitro human skin model evaluation of oil control efficacy of cosmetics
  • T/CVMA 17-2020 Newcastle disease virus V protein antibody indirect ELISA detection method
  • T/LNBHXH 003-2023 In vitro human skin model test method for evaluating the firming and anti-wrinkle efficacy of cosmetics
  • T/AHPCA 049-2023 Testing method for anti-wrinkle and firming efficacy of cosmetics (rapid free radical scavenging assay)
  • T/GDCDC 024-2022 Method for assessment of cosmetics oil control efficacy
  • T/GDCA 038-2024 Human evaluation method for assessing the skin irritation relieving effects of cosmetics
  • T/CVMA 114-2023 Method of iELISA for detection of antibodies against Rabies virus in dogs and cats
  • T/GDCDC 019-2021 Evaluation method for anti-wrinkle of skincare products
  • T/LNBHXH 002-2023 Test method for in vitro human skin model evaluation of cosmetic firming efficacy
  • T/COCIA 10-2020 Clinical method for evaluation of anti-calculus effect of toothpaste efficacy of oral cleaning care products
  • T/GDCA 009-2022 Evaluation method for repairing efficacies of cosmetics
  • T/CVMA 167-2024 Magnetic particle chemiluminescence method for detection of antibody against classical swine fever virus
  • T/SDCIA 1011-2022 Cosmetic Firming Efficacy - Human Body Efficacy Evaluation Test Method
  • T/GDCA 048-2024 Evaluation method for scalp repairing efficacy
  • T/CVMA 130-2023 Indirect magnetic particle based chemiluminescence immunoassay for detecting antibodies against classical swine fever virus
  • T/WSJD 15.1-2020 Testing and evaluation methods for the protective effect of vibration-absorbing gloves—Part 1: Testing and evaluation methods for finger vibration transmissibility
  • T/COCIA 9-2020 Clinical method for evaluation of anti-halitosis effect of toothpaste efficacy of oral care products
  • T/SAIA 004-2021 Antibody detection method of swine fever virus PPA-ELISA
  • T/CVMA 158-2024 Fluorescence polarization assay for detection of antibodies against Mycobacterium bovis
  • T/LNBHXH 004-2023 Test method for in vitro human skin model evaluation of soothing efficacy of cosmetics
  • T/QLMZ 1-2022 Anti-wrinkle efficacy evaluation method of cosmetics based on zebrafish model
  • T/CVMA 86-2021 Competitive ELISA detection method of antibodies against pocine Seneca virus A infection
  • T/ZHCA 006-2019 Method for assessment of cosmetics anti-wrinkle efficacy
  • T/AHPCA 047-2023 Method for testing the anti-wrinkle and firming efficacy of cosmetics (elastase inhibition rapid assay)
  • T/SDAS 456-2022 Anti-wrinkle efficacy evaluation method of cosmetics based on zebrafish model
  • T/AHPCA 044-2023 Anti-wrinkle and firming efficacy test method of cosmetics (zebrafish embryo oxidative stress model)
  • T/LNBHXH 004-2024 Soothing efficacy test of cosmetics – In vitro human skin test method
  • T/LNBHXH 001-2023 In vitro human epidermal model test method for evaluation of moisturizing efficacy of cosmetics
  • T/WSWXH 009-2024 Methods for evaluating the effectiveness of cotton fusarium wilt antagonistic bacteria control
  • T/AHPCA 048-2023 Test method for anti-wrinkle and firming efficacy of cosmetics (test for anti-non-enzymatic glycosylation ability)
  • T/CVMA 169-2024 Indirect enzyme-linked immunosorbent assay for detection of antibodies against fowl adenovirus serotype 4
  • T/FDSA 002-2019 Test method for physically anti-fouling evaluation of biomimicry micropatterned surfaces
  • T/CVMA 14-2020 Hemagglutination inhibition detection method for duck Tembusu virus antibody
  • T/SHRH 022-2019 Moisturizing efficacy test of cosmetics - In vitro reconstructed human skin test method
  • T/GXAS 722-2024 Indirect N-ELISA method for detection of antibody against avian metapneumovirus
  • T/ZFB 0046-2023 Performance evaluation of technical equipment project of inspection and testing
  • T/SDCIA 1010-2022 Cosmetic Repair Efficacy - Human Body Efficacy Evaluation Test Method

Chongqing Provincial Standard of the People's Republic of China

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 27535-2011 Detection method of hemagglutination inhibition antibody against swine influenza
  • GB/T 21510-2024 Antimicrobial property testing and evaluation methods for nano-inorganic materials
  • GB/T 13217.8-2009 Test method for blocking resistance of liquid ink

中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会

  • GB/T 35939-2018 Indirect enzyme linked immunosorbent assay for detecting the antibody against encephalomyocarditis virus
  • GB/T 35906-2018 Indirect ELISA to detect antibody against classical swine fever virus
  • GB/T 35910-2018 Blocking enzyme-linked immunosorbent assay for detecting the antibody to porcine circovirus type 2
  • GB/T 34729-2017 Blocking ELISA method to detect antibody against classical swine fever virus

Professional Standard - Light Industry

  • QB/T 2738-2012 Test methods for evaluating daily chemical products in antibacterial and bacteriostatic efficacy
  • QB/T 2738-2023 Evaluating methods for antibacterial and bacteriostatic efficacy of daily chemical products
  • QB/T 2738-2005 Test methods for evaluating daily chemical products in antibacterial and bacterioustatic efficacy

Professional Standard - Commodity Inspection

  • SN/T 1182.1-2003 Detection antibodies against avian influenza virus--Procotol of agar gel immuno-difusion test
  • SN/T 3949-2014 Plastic package - Determination of harmful material bisphenol A-Conjuction of antigen and antibody method
  • SN/T 1226-2003 Detection antibodies against fowl pox virus - Protocol of hemagglutination inhibition test
  • SN/T 1222-2003 Detection of antibodies against(pullorum disease) - Protocaol of whole blood plate agglutination test
  • SN/T 2987-2011 Colloidal Gold Immunofiltration Dot Detection for Cysticercosis Cellulosae Antibody
  • SN/T 1177-2003 Protocol of test for B virus related antibodies in monkey
  • SN/T 1174-2003 Antibody detection methods for simian retrovirus type D

Fujian Provincial Standard of the People's Republic of China

  • DB35/T 916-2009 Detection method of swine fever antibody gold standard test paper

Hubei Provincial Standard of the People's Republic of China

  • DB42/T 1589-2020 H7 Subtype Avian Influenza Virus Competitive ELSIA Antibody Detection Method
  • DB42/T 734-2011 Colloidal Gold Strips to Detect the Antibody against Mycobacterium bovis
  • DB42/T 894-2013 Antibody detection method of Actinobacillus pleuropneumoniae ApxIV-ELISA
  • DB42/T 790-2012 Influenza A H1N1 Influenza Virus Double Antibody ELISA Detection Method
  • DB42/T 789-2012 Streptococcus suis type 2 ELISA antibody detection method
  • DB42/T 792-2012 Detection method of latex agglutination antibody against porcine Japanese encephalitis

Professional Standard - Forestry

  • LY/T 1926-2010 Antimicrobial wood (bamboo)-based flooring—Test method for antimicrobial function and antimicrobial effect

农业农村部

  • NY/T 3468-2019 Indirect enzyme-linked immunosorbent assay for detection of antibodies against porcine rotavirus

Xinjiang Provincial Standard of the People's Republic of China

Sichuan Provincial Standard of the People's Republic of China

  • DB51/T 2306-2016 Indirect ELISA Antibody Detection Method of Duck Hepatitis A Virus
  • DB51/T 2304-2016 Detection method of Haemophilus parasuis indirect ELISA antibody

National Metrological Technical Specifications of the People's Republic of China

  • JJF 1614-2017 Calibration Specification for Antibiotics Potency Analyzers

Shanxi Provincial Standard of the People's Republic of China

  • DB14/T 1804-2019 Porcine epidemic diarrhea virus antibody ELISA detection method
  • DB14/T 1789-2019 Competitive ELISA detection method for H7 subtype antibody of avian influenza virus

Shandong Provincial Standard of the People's Republic of China

  • DB37/T 2843-2016 Duck Tembusu virus double antibody sandwich ELISA detection method

国家市场监督管理总局、中国国家标准化管理委员会

  • GB/T 40999-2021 Quality assessment requirements for Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2) total antibody detection kit
  • GB/T 40983-2021 Quality assessment requirements for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) IgG antibody detection kit
  • GB/T 40185-2021 Determination of 5 kinds of ammonium chloride antibacterial agents in toothpaste—High performance liquid chromatography method
  • GB/T 40984-2021 Quality assessment requirements for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)IgM antibody detection kit

Anhui Provincial Standard of the People's Republic of China

  • DB34/T 3407-2019 Porcine epidemic diarrhea virus IgA antibody indirect ELISA detection method
  • DB3418/T 020-2022 Guidelines for Service Performance Evaluation of Inspection and Testing Institutions

Inner Mongolia Provincial Standard of the People's Republic of China

  • DB15/T 2741-2022 Indirect ELISA method for detecting the antibody of Mansonella ovis hemolyticus

国家食品药品监督管理局

  • YY/T 1497-2016 Evaluation test method for the viral filtration efficiency(VFE)of medical protective face mask materials―Test method using Phi-X174 bacteriophage

Military Standard of the People's Republic of China-General Armament Department

American Society for Testing and Materials (ASTM)

  • ASTM E1054-02 Standard Test Methods for Evaluation of Inactivators of Antimicrobial Agents

HU-MSZT

SCC

  • BS ISO 12206:1995 Photography. Methods for the evaluation of the effectiveness of chemical conversion of silver images against oxidation
  • AWWA QTC98241 Specific Antibodies for Water Testing: the Good the Bad and the IgG1

Japanese Industrial Standards Committee (JISC)

  • JIS A 1455:2002 Anti-static effect of floor coverings and installed floors -- Methods of measurement and evaluation

CN-STDBOOK

  • 图书 3-9873 Evaluation Method of Benefits in Systematic Implementation of Technical Standards

Korean Agency for Technology and Standards (KATS)

  • KS P 1800-2013 Protocol for evaluation of matrix effects in in-vitro diagnostic test

GSO

  • NB/T 11434.3-2023 Coal mine paste filling part 3 effect evaluation method
  • OS GSO ISO 18915:2013 Imaging materials -- Methods for the evaluation of the effectiveness of chemical conversion of silver images against oxidation

British Standards Institution (BSI)

  • BS ISO 18915:2000 Imaging materials. Methods for the evaluation of the effectiveness of chemical conversion of silver images against oxidation

RU-GOST R